Webinar
The Deep Tech Frontier: 10 Game-Changing Companies
Join Alumni Ventures Managing Partner Matt Caspari for a forward-looking session exploring the next wave of innovation emerging from deep tech.
This webinar will spotlight ten breakthrough startups operating at the intersection of advanced science and commercialization—from quantum computing and AI robotics to materials engineering and space technologies. Matt will share why these companies are poised to reshape industries and how Alumni Ventures evaluates high-potential opportunities in complex, frontier markets.
You’ll gain insight into the investment thesis behind each deal and learn how deep tech fits into a diversified venture portfolio. Whether you’re a seasoned investor or curious about what’s next, this session will offer a rare peek into the technologies shaping our future. Reserve your spot today to explore the frontier of venture innovation.
Why Attend?
- HomeDiscover ten high-potential startups backed by AV in deep tech
- HomeUnderstand how venture capital identifies winners in complex markets
- HomeLearn directly from Matt Caspari about trends shaping the next decade
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Managing Partner, Deep Tech Fund
Matt Caspari is a Managing Partner at Alumni Ventures, where he leads the Deep Tech, Georgetown (Potomac Ventures) and UC Berkeley (Strawberry Creek Ventures) funds. He invests in mission-driven founders developing groundbreaking technologies. His investments encompass a diverse range of sectors, including AI, agriculture, aviation, battery technology, cybersecurity, direct air capture of CO2, energy generation, longevity, and robotics. Prior to Alumni Ventures, Matt gained operational experience as a two-time venture-backed founder/CEO and as a leader of the innovation team at Nike. He was the founding CEO of Aurora Biofuels, a deep tech venture that grew to 100+ employees, secured over $100 million in funding and was acquired by Reliance Industries. In earlier roles, Matt served as a strategic management consultant at Cambridge Pharma Consultancy, later acquired by IMS Health, and gained experience on the M&A team at Bloomberg. He holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.